|
New
Influenza Vaccine( Fluarix) approved by the FDA for Upcoming
Flu Season
August
31, 2005
The
Food and Drug Administration (FDA) today approved Fluarix, an influenza
vaccine for adults that contains inactivated virus. Fluarix
is approved to immunize adults 18 years of age and older against influenza
virus types A and B contained in the vaccine. Influenza is also
commonly called the flu.
Important features of Fluarix.
-
To
immunize adults 18 years of age and older against influenza virus types A and
B contained in the vaccine.
-
First vaccine
approved using FDA"s accelerated approval
process.
-
GlaxoSmithKline is the manufacturer of Fluarix.
Some facts about Influenza in United States
-
More than 200,000 people are hospitalized from flu complications
each year
-
About 36,000 people die from flu each year.
-
No vaccine is 100% effective against preventing disease
but vaccination offered the best protection against influenza and
can prevent many illnesses and deaths.
For more information visit
http://www.fda.gov/bbs/topics/news/2005/NEW01227.html
|